SendStory Logo

Shionogi applies for COVID-19 vaccine approval, would be first Japan-made

Japan Times LogoJapan Times2d ago

Shionogi applies for COVID-19 vaccine approval, would be first Japan-made

Quick Summary

The recombinant protein-based preventive vaccine is the same type as a COVID-19 vaccine developed by Novavax and differs from messenger RNA vaccines developed by Pfizer ...

It has marked the first application of a COVID-19 vaccine developed in Japan.

Osaka – Pharmaceutical firm Shionogi said Thursday it has applied with the health ministry for approval of its coronavirus vaccine.


More Pictures

News Analysis

Author / Journalist: No Author

Category: Nation Politics

Topics: List Subscription Coronavirus First Ministry Japan Shionogi Approval Vaccine Sites Plan

Source Website Secure: Yes (HTTPS)

Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

News Source URL: japantimes.co.jp

Readership Location: Japan

Published Date: 2022-11-24, 18:19:03

News Timezone: GMT +9:00

Language: English

Original Article Length: 217 words

Reading Duration: 2 minutes read

Compatibility: Desktop Web, Mobile Web, iOS App, Android App

News ID: 5565769

Load More

About Publisher

Japan Times Logo

Name: Japan Times

Main Topics: NationPolitics

Official Website: japantimes.co.jp

Update Frequency: 40 posts per day

Last Update: 14h ago

Headquarters: Japan

Coverage Areas: Japan

Publication Owner: Independent Company

Publication Timezone: GMT +9:00

Languages Covered: English

RSS Feed: Available (XML)

API Available: Yes

Website Security: Secure (HTTPS)

Publisher ID: #132

Load More

SendStory makes reading the news super fast, short, and sweet by summarizing every story into 3 sentences. Our mission is to create an informed generation of people by making news extremely easy to read, while saving your precious time staying informed.

© Copyright 2022 SendStory. All Rights Reserved.